Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Eli Lilly and Company
Eastern Cooperative Oncology Group
University of California, Davis
Eli Lilly and Company
Case Comprehensive Cancer Center